Evidence map›Paper›PMID 36980170›Full record

ArticleCells2023

iProm-Sigma54: A CNN Base Prediction Tool for

Muhammad Shujaat, Hoonjoo Kim, Hilal Tayara, Kil To Chong

Open access · goldFull text read
In one paragraph

Article in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. ProPr54 web server: predicting σNAR genomics and bioinformatics · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Muhammad ShujaatDepartment of Electronics and Information Engineering, Jeonbuk National University, Jeonju 54896, Republic of Korea.ORCID 0000-0003-1752-3927
Hoonjoo KimSchool of Pharmacy, Jeonbuk National University, Jeonju 54896, Republic of Korea.
Hilal TayaraSchool of International Engineering and Science, Jeonbuk National University, Jeonju 54896, Republic of Korea.ORCID 0000-0001-5678-3479
Kil To ChongDepartment of Electronics and Information Engineering, Jeonbuk National University, Jeonju 54896, Republic of Korea.ORCID 0000-0002-1952-0001
Jeonbuk National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The sigma (σ) factor of RNA holoenzymes is essential for identifying and binding to promoter regions during gene transcription in prokaryotes. σ54 promoters carried out various ancillary methods and environmentally responsive procedures; therefore, it is crucial to accurately identify σ54 promoter sequences to comprehend the underlying process of gene regulation. Herein, we come up with a convolutional neural network (CNN) based prediction tool named "iProm-Sigma54" for the prediction of σ54 promoters. The CNN consists of two one-dimensional convolutional layers, which are followed by max pooling layers and dropout layers. A one-hot encoding scheme was used to extract the input matrix. To determine the prediction performance of iProm-Sigma54, we employed four assessment metrics and five-fold cross-validation; performance was measured using a benchmark and test dataset. According to the findings of this comparison, iProm-Sigma54 outperformed existing methodologies for identifying σ54 promoters. Additionally, a publicly accessible web server was constructed.

Indexed as

DNA-Directed RNA PolymerasesSigma FactorNeural Networks, ComputerPromoter Regions, GeneticRNA Polymerase Sigma 54DNA-Directed RNA PolymerasesRNA Polymerase Sigma 54Sigma Factorbioinformaticscomputational biologyconvolutional neural networksdeep learningDNA promoterssigma factors

Identifiers

PMID36980170
PMCPMC10047130
OpenAlexW4323568641

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read11
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.